HCA HOUSTON HEALTHCARE TOMBALL — History
CCN 450670 | 3-year financial timeline | COVID resilience: 56/100
🛡️ Public data only — no PHI permitted on this instance.
$215M
Latest Revenue (FY2022)
+0.8%
Revenue CAGR (3yr)
2.4%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $211M | $215M | $215M | -0.1% | +0.8% |
| Operating Expenses | $208M | $212M | $210M | -1.2% | +0.3% |
| Operating Margin | 1.3% | 1.3% | 2.4% | +84.9% | +33.1% |
| Net Income | $3M | $3M | $5M | +84.7% | +34.2% |
| Licensed Beds | 194 | 181 | 205 | +13.3% | +2.8% |
| Total Patient Days | 42,338 | 43,183 | 39,191 | -9.2% | -3.8% |
| Medicare Day % | 25% | 21% | 20% | -4.7% | -10.1% |
| Medicaid Day % | 3% | 4% | 3% | -19.9% | +3.6% |
COVID Impact & Recovery
Resilience Score: 56/100 — Moderate — some COVID impact but recovering
Revenue recovery from FY2020 to FY2022: +1.7% ($211M → $215M)
FY2020 captured the initial COVID shock. Slow recovery suggests structural challenges beyond COVID.
Trend Summary
Revenue▶ Stable
Operating Margin▲ Growing
Beds▲ Growing
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+0.8%
This Hospital
+7.6%
State Avg
Latest Margin
2.4%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $217M | 2.9% |
| FY2024 (proj) | $218M | 3.4% |
| FY2025 (proj) | $220M | 3.9% |